메뉴 건너뛰기




Volumn 205, Issue 1, 2002, Pages 1-2

The Schnitzler syndrome - A treatment at last?

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIHISTAMINIC AGENT; ANTIMALARIAL AGENT; COLCHICINE; DAPSONE; IMMUNOGLOBULIN; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1 ANTIBODY; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6 RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; PARAPROTEIN; STEROID;

EID: 0036976354     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063143     Document Type: Editorial
Times cited : (10)

References (9)
  • 1
    • 84863639614 scopus 로고
    • Lésions urticariennes chroniques permanentes (érythème pétaloïde?) Cas cliniques
    • octobre
    • Schnitzler L: Lésions urticariennes chroniques permanentes (érythème pétaloïde?) Cas cliniques, No 46 B. Journée Dermatologique d'Angers, octobre 1972.
    • (1972) Journée Dermatologique d'Angers , vol.46 B
    • Schnitzler, L.1
  • 3
    • 0025909461 scopus 로고
    • Schnitzler's syndrome: A broader clinical spectrum
    • Berdy SS, Bloch KJ: Schnitzler's syndrome: A broader clinical spectrum. J Allergy Clin Immunol 1991;87:849-854.
    • (1991) J Allergy Clin Immunol , vol.87 , pp. 849-854
    • Berdy, S.S.1    Bloch, K.J.2
  • 5
    • 0026045827 scopus 로고
    • Anti-interleukin-1 alpha autoantibodies in humans: Characterization, isotype distribution, and receptor-binding inhibition - Higher frequency in Schnitzler's syndrome (urticaria and macroglobulinemia)
    • Saurat JH, Schifferli J, Steiger G, Dayer JM, Didierjean L: Anti-interleukin-1 alpha autoantibodies in humans: Characterization, isotype distribution, and receptor-binding inhibition - Higher frequency in Schnitzler's syndrome (urticaria and macroglobulinemia). J Allergy Clin Immunol 1991;88:244-256.
    • (1991) J Allergy Clin Immunol , vol.88 , pp. 244-256
    • Saurat, J.H.1    Schifferli, J.2    Steiger, G.3    Dayer, J.M.4    Didierjean, L.5
  • 7
    • 0034933036 scopus 로고    scopus 로고
    • Interferon as therapy for multiple myeloma: An individual patient data overview of 24 randomized trials and 4,012 patients
    • Anonymous: Interferon as therapy for multiple myeloma: An individual patient data overview of 24 randomized trials and 4,012 patients. Br J Haematol 2001;113:1020-1034.
    • (2001) Br J Haematol , vol.113 , pp. 1020-1034
  • 8
    • 0035496921 scopus 로고    scopus 로고
    • Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma
    • Chen Q, Gong B, Mahmoud-Ahmed AS, Zhou A, Hsi ED, Hussein M, Almasan A: Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma. Blood 2001;98:2183-2192.
    • (2001) Blood , vol.98 , pp. 2183-2192
    • Chen, Q.1    Gong, B.2    Mahmoud-Ahmed, A.S.3    Zhou, A.4    Hsi, E.D.5    Hussein, M.6    Almasan, A.7
  • 9
    • 0036973355 scopus 로고    scopus 로고
    • Successful treatment of Schnitzler's syndrome with interferon alfa-2b
    • Kuenzli S, Bucher S, Saurat JH: Successful treatment of Schnitzler's syndrome with interferon alfa-2b. Dermatology 2002;205:74.
    • (2002) Dermatology , vol.205 , pp. 74
    • Kuenzli, S.1    Bucher, S.2    Saurat, J.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.